Stock Movers Fox Rises, Pfizer Higher, Kenvue Falls As Trump Admin to Links Tylenol to Autism.
Sep 22, 2025
Fox's shares climb after hints of Murdoch's involvement in a TikTok takeover. Pfizer makes waves by acquiring obesity startup Metsera for $4.9 billion, aiming to enhance its weight-loss offerings. Meanwhile, Kenvue's stock takes a hit following a controversial report linking Tylenol to autism, raising concerns for pregnant women. The market's reaction is palpable as these developments unfold.
AI Snips
Chapters
Transcript
Episode notes
Murdochs Could Boost Fox Via TikTok
- Fox shares rose after President Trump suggested Lachlan and Rupert Murdoch could be involved in a TikTok deal.
- Bloomberg Intelligence says TikTok ownership could give Fox a social-media foothold as linear TV faces secular decline.
Pfizer Expands In Obesity With MetSera Deal
- Pfizer agreed to buy obesity startup MetSera for $4.9 billion plus up to $22.50 per share in milestones, potentially totaling $7.3 billion.
- Bloomberg Intelligence says the deal could catapult Pfizer up the obesity drug ladder by giving access to competitive injectable treatments.
Tylenol Concerns Hit Kenvue Stock
- Kenvue shares fell over 5% after reports the U.S. administration will link Tylenol's active ingredient to autism and warn pregnant women about use.
- Bloomberg Intelligence warns reduced Tylenol demand would complicate Kenvue's return to EPS growth amid existing autism-related lawsuits.